- Home
- BMRN vs MTZ Comparison
BMRN vs MTZ Comparison
Compare BMRN & MTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- MTZ
- Stock Information
- Founded
- BMRN 1996
- MTZ 1929
- Country
- BMRN United States
- MTZ United States
- Employees
- BMRN N/A
- MTZ N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- MTZ Water Sewer Pipeline Comm & Power Line Construction
- Sector
- BMRN Health Care
- MTZ Industrials
- Exchange
- BMRN Nasdaq
- MTZ Nasdaq
- Market Cap
- BMRN 12.1B
- MTZ 12.8B
- IPO Year
- BMRN 1999
- MTZ N/A
- Fundamental
- Price
- BMRN $55.00
- MTZ $163.58
- Analyst Decision
- BMRN Buy
- MTZ Strong Buy
- Analyst Count
- BMRN 22
- MTZ 18
- Target Price
- BMRN $93.43
- MTZ $164.59
- AVG Volume (30 Days)
- BMRN 2.2M
- MTZ 724.1K
- Earning Date
- BMRN 08-04-2025
- MTZ 07-31-2025
- Dividend Yield
- BMRN N/A
- MTZ N/A
- EPS Growth
- BMRN 152.82
- MTZ N/A
- EPS
- BMRN 2.71
- MTZ 2.70
- Revenue
- BMRN $2,950,227,000.00
- MTZ $12,464,333,000.00
- Revenue This Year
- BMRN $12.23
- MTZ $12.37
- Revenue Next Year
- BMRN $9.99
- MTZ $8.88
- P/E Ratio
- BMRN $20.29
- MTZ $60.10
- Revenue Growth
- BMRN 19.36
- MTZ 3.03
- 52 Week Low
- BMRN $52.93
- MTZ $89.96
- 52 Week High
- BMRN $94.85
- MTZ $166.95
- Technical
- Relative Strength Index (RSI)
- BMRN 35.12
- MTZ 63.46
- Support Level
- BMRN $54.46
- MTZ $159.98
- Resistance Level
- BMRN $58.17
- MTZ $166.42
- Average True Range (ATR)
- BMRN 1.39
- MTZ 4.21
- MACD
- BMRN -0.04
- MTZ -0.59
- Stochastic Oscillator
- BMRN 13.08
- MTZ 78.91
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About MTZ MasTec Inc.
MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. The company's primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; oil and gas; power delivery; and other.